Leimer, Birgit; Pradella, Fabienne; Fruth, Anja et al.
Ramadan Observance during Pregnancy in Germany: a Challenge for Prenatal CareGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 78. H. 7. 2018 S. 684-689
Zhu, A. X.; Finn, R. S.; Galle, P. R. et al.
Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP) following first-line sorafenib: Patient reported outcome results across two phase III studies (REACH-2 and REACH)ANNALS OF ONCOLOGY. Bd. 29. 2018 S. 208-208
Llovet, Josep M.; Kudo, Masatoshi; Finn, Richard et al.
Ramucirumab As Second-Line Treatment in Patients with Hepatocellular Carcinoma (HCC) and Elevated Alpha-Fetoprotein (AFP) Following Sorafenib: Pooled Results from Two Global Phase 3 Studies (REACH-2 and REACH)HEPATOLOGY. Bd. 68. 2018 S. 166A-166A
Stockmann, M.; Vondran, F. W. R.; Fahrner, R. et al.
Randomized clinical trial comparing liver resection with and without perioperative assessment of liver functionBJS OPEN. Bd. 2. H. 5. 2018 S. 301-309
Eichelsbacher, C.; Ilper, H.; Noppens, R. et al.
Rapid sequence induction and intubation in patients with risk of aspiration. Recommendations for action for practical management of anesthesiaANAESTHESIST. Bd. 67. H. 8. 2018 S. 568-583
Archavlis, Eleftherios; Amr, Nimer; Kantelhardt, Sven Rainer et al.
Rates of Upper Facet Joint Violation in Minimally Invasive Percutaneous and Open Instrumentation: A Comparative Cohort Study of Different Insertion TechniquesJOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY. Bd. 79. H. 1. 2018 S. 1-8
Weyerhauser, Patrick; Kantelhardt, Sven R.; Kim, Ella L.
Re-purposing Chloroquine for Glioblastoma: Potential Merits and Confounding VariablesFRONTIERS IN ONCOLOGY. Bd. 8. 2018
Zhu, Andrew X.; Kang, Yoon-Koo; Yen, Chia-Jui et al.
REACH-2: A randomized, double-blind, placebo-controlled phase 3 study of ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma (HCC) and elevated baseline alpha-fetoprotein (AFP) following first-line sorafenib.JOURNAL OF CLINICAL ONCOLOGY. Bd. 36. H. 15. 2018
Buggisch, Peter; Vermehren, Johannes; Mauss, Stefan et al.
Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis CJOURNAL OF HEPATOLOGY. Bd. 68. H. 4. 2018 S. 663-671
Foerster, Friedrich; Mittler, Jens; Darstein, Felix et al.
Recipient liver function before liver transplantation influences post-transplantation survival in patients with HCCEUROPEAN JOURNAL OF INTERNAL MEDICINE. Bd. 55. 2018 S. 57-65